Oct 2026· Frontiers in Immunology· Vol 17· 0 citations· 215 references
Medicine
Abstract
Liver fibrosis is a defining feature of chronic liver diseases and can progress to cirrhosis and liver failure. Single-cell RNA sequencing (scRNA-seq) enables high-resolution analysis of cellular heterogeneity and multicellular interactions during fibrogenesis. In this narrative review, we analyzed published single-cell transcriptomic studies from experimental models and human cohorts, focusing on cell-type–specific programs, cell-state trajectories inferred by Monocle, and intercellular communication networks predicted using CellChat and CellPhoneDB. Hepatic stellate cells (HSCs) consistently emerged as the primary extracellular matrix–producing cells, with conserved activation signatures involving collagen synthesis, Phosphatidylinositol 3-kinase–Protein kinase B (PI3K–AKT) signaling, and matrix organization. Macrophage analyses identified fibrosis-associated subsets, including CD9+ and TREM2+ scar-associated macrophages (SAMs), which regulate inflammation, angiogenesis, and stromal remodeling. Liver sinusoidal endothelial cells undergo capillarization and transcriptional reprogramming linked to WNT signaling and antigen presentation. B cells exhibit activation signatures related to B-cell receptor signaling. Trajectory analyses infer potential cell-state transitions based on transcriptional similarity from quiescent to pathogenic states, including stepwise HSC activation and monocyte-to-macrophage differentiation. Cell–cell communication analysis highlights HSC–macrophage interactions, with key axes such as predicted Chemokine ligand 2–chemokine receptor 2 (CCL2–CCR2) and transforming growth factor-β–transforming growth factor-β receptor (TGFβ–TGFβR) signaling interactions that may contribute to fibrogenic communication networks. These findings define conserved multicellular programs and support integrated multi-omics approaches for biomarker discovery and therapy.
Liver fibrosis, a common pathological outcome of chronic liver diseases, is a dynamic process characterized by molecular and cell interactions. Transcription factors (TFs) are key in modulating gene expression programs that govern hepatocyte fate, metabolic homeostasis, inflammation and extracellular matrix remodeling....
Xian-Fei Zhou, Chong-Jun Yang, Zhi-Yong Weng et al.· International Journal of Mol...· 0 citations
Summary Pulmonary hypertension (PH) is a progressive vascular disease, yet the underlying cell-type-specific molecular networks and diagnostic biomarkers remain incompletely defined. Integrating single-cell and bulk transcriptomics, we identified 14 pulmonary cell types in PH, with smooth muscle cells (SMCs) as a centr...
Pei-Pei Wu, Jing-Ru Huan, Cheng-Liang Liu et al.· iScience· 0 citations
Background and Aims Biliary atresia (BA) is a severe pediatric cholangiopathy characterized by rapidly progressive liver fibrosis. This study aimed to characterize scar-associated macrophages and investigate the role of plasminogen (PLG)–plasminogen receptor with a C-terminal lysine (PLGRKT) signaling in BA-associated...
Xin Li, Teng-Fei Li, Shao-Wen Liu et al.· Journal of Clinical and Tran...· 0 citations
Liver fibrosis is a dynamic and potentially reversible consequence of chronic liver injury, shaped by persistent inflammation, metabolic disturbance, and impaired tissue repair. Accumulating evidence indicates that, rather than operating as independent processes, immune activation, metabolic reprogramming, and cellular...
Ya-Xuan Cao, Yan Chen, K. Tam· Clinical science· 0 citations
Diabetic nephropathy (DN) arises through complex pathological mechanisms that remain incompletely understood. This study employs transcriptomic and single-cell RNA sequencing (scRNA-seq) approaches to systematically characterize gene expression patterns, cellular composition changes, and intercellular communication net...
Li Qin, Yan Liang, Li-Ying Xuan et al.· American Journal of Nephrolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.